A majority of Colombian women get Pap smears, but new studies show that ten percent of such tests administered in Colombia yield inaccurate results.
The LA Times calls HHS proposal a ‘sneak attack on family planning'; HPV vaccine banned from Catholic school in UK; HIV rates among drug users worldwide rises; Wall Street takes welfare it begrudges to women; Why the election matters for reproductive rights; Jesuit priest embraces social support programs to reduce abortion; Remote control male birth control.
A teen’s sexual activity doesn’t predict her future risk for HPV, and shouldn’t determine whether she receives the HPV vaccine, University of Michigan researchers find.
Watch video of McCain squirming for eight long seconds in response to a birth control question, Birth control prices continue to rise, Catching up on RH issues in Latin America.
In Latin America and the Caribbean, 33,000 women die of cervical cancer each year. What is blocking universal access to testing and treatment?
Only two steps remain in Iowa’s legislative quest to require insurance companies to provide coverage of vaccinations for the human papillomavirus, the major cause of cervical cancer.
Women’s access to unbiased, medically-sound reproductive health care in Canada is being compromised by doctors hiding behind conscience clauses to refuse services and referrals.
Both male circumcision and the new HPV vaccine have been called “no-brainers” in the fight to reduce HIV and HPV infection rates. But are they really the magic bullet solutions that they seem to be?
A new study has found that administering the HPV vaccine based on a woman’s risk factors could prevent access for the vast majority of eligible women. The study supports a federal recommendation that all females ages 11 to 26 should get the vaccine.
Despite the recognized benefits of universal programs aimed at young girls there is still a need to raise concerns about vulnerable and disadvantaged groups of women who are simply falling through the cracks.